PubMed HealthSearch

PubMed · 9355522

MRSA.

Abstract

All nurses are likely to encounter methicillin-resistant Staphylococcus aureus (MRSA) at some time in their career, and they are also likely to observe that approaches to containing it vary from hospital to hospital and within different care settings. This Learning Unit aims to explore these apparent contradictions, and identify the elements of practice common to all care settings. The associated television component makes clear that the needs of the patient are central to all approaches to tackling MRSA. The themes of this workbook are based on the settings in which care is given. The settings are important as predictors of the acquisition and spread of MRSA, because they indicate the vulnerability of the patients within them, and the kind of treatment and care the patients are likely to receive. Susceptibility to MRSA is linked to surgery, to the use of invasive devices and to the immune state of the patient. The physical environment, the fixtures and fittings, furniture and equipment, are seldom implicated in the spread of MRSA. MRSA lives on skin, and it is skin that helps it to spread, particularly on the hands of healthcare workers. The focus of this workbook is on the simple, everyday practices which interrupt this method of spread. This Unit is relevant to the UKCC Professional Development Categories: Care enhancement and Reducing risk.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L Taylor. 1997-08-27. MRSA.. https://pubmed.ncbi.nlm.nih.gov/9355522/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates.

OBJECTIVE: We carried out a randomized placebo-controlled trial in very low birth weight neonates (VLBWNs), comparing the incidence of nosocomial infections after the prophylactic use of recombinant human granulocyte-macrophage colony-stimulating factor (rhu GM-CSF) versus placebo in VLBWNs. STUDY DESIGN: VLBWNs (n = 264), weighing 501 to 1000 g, </=72 hours of age were randomly assigned to receive rhu GM-CSF (8 microg/kg/d), administered intravenously (n = 134) over 2 hours daily x 7 days and every other day for 21 days, or placebo (n = 130). The safety, incidence of nosocomial infections, days of absolute neutrophil count >/=4000/mm,3 peripheral blood progenitor studies, and 24-hour polymorphonuclear leukocyte C3bi receptor expression were compared between the 2 treatment groups. RESULTS: No (grade III/IV) toxicity or adverse events were associated with rhu GM-CSF. The absolute neutrophil count and absolute eosinophil count were significantly elevated in the rhu GM-CSF group on days 7 (P =.001), 14 (P =.001), and 21 (P =.007) and on days 7 and 28 (P =.012 and P =.001, respectively). However, there was no difference in the incidence of confirmed nosocomial infections between the 2 treatment groups in this trial (40% vs 39%, rhu GM-CSF vs placebo; P = NS). CONCLUSION: In a large randomized placebo-controlled trial, prophylactic administration of rhu GM-CSF in VLBWNs does not appear to decrease the incidence of nosocomial infections.

Cross Infection

[Emergence of new-risk factors associated with nosocominal infection].

During the last several decades, we have experienced the emerging and reemerging of infectious pathogens and diseases. The outbreaks of infection due to these pathogens sometimes occur via the sources and/or routes which have not been recognized during previous studies on epidemiology and pathogenesis of the diseases. There are many factors contributing to the increase in infectious diseases. Namely, medical progress often results in an increasing number of immunocompromised patients. Common, usually avirulent, commensal and environmental organisms become pathogens to these patients. The evolution of organisms acquiring resistance to antimicrobial agents, disinfectants, and environmental stimuli also relates to the high incidence of nosocominal (hospital-acquired) infections as well as to the clinical situation of the patients. Because of these tendencies, as risks of nosocominal infections, are characteristic especially in major health care centers such as large teaching hospitals, most health care workers are obliged to participate actively in control and preventive efforts in addition to their traditional roles. In this review I discuss the recent characteristics of nosocominal pathogens and the environments surrounding the hospitalized patients to design effective strategies for and to facilitate the infection control activities.

Cross Infection

[Spread of methicillin-resistant Staphylococcus aureus. Are our hygienic precautions sufficient?].

A patient was transferred from Pakistan to a Danish orthopaedic ward. In Denmark he was tested MRSA-positive. Two months after he was discharged, similar MRSA strains were found in another patient. The two patients had been on the same ward for one week. All hygienic precautions had been taken. Staff and other patients on the ward at the relevant time all tested MRSA-negative.

Cross Infection